Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models (Q45862754)

17 December 2017

title

Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models (English)

1 reference

17 December 2017

1 reference

S Y Wu

1

1 reference

17 December 2017

A Singhania

2

1 reference

17 December 2017

M Burgess

3

1 reference

17 December 2017

L N Putral

4

1 reference

17 December 2017

C Kirkpatrick

5

1 reference

17 December 2017

N M Davies

6

1 reference

17 December 2017

N A J McMillan

7

1 reference

17 December 2017

language of work or name

1 reference

12 August 2010

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

18

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

14-22

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2010.113

exact match

0 references

cites work

Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

RNA interference for the treatment of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Tumor-targeted delivery of siRNA by self-assembled nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Chapter 14: HPV vaccine introduction in industrialized countries

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Chemotherapy for advanced, recurrent, and metastatic cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs).

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Gene silencing by systemic delivery of synthetic siRNAs in adult mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emissi

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

In vivo imaging of siRNA delivery and silencing in tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Molecular profiling of cervical cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Evaluation of proinflammatory cytokine production and liver injury induced by plasmid DNA/cationic liposome complexes with various mixing ratios in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Incorporation of all-trans retinoic acid into lipoplexes inhibits nuclear factor kappaB activation mediated liver injury induced by lipoplexes in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.113

7 January 2021

Identifiers

DOI

10.1038/GT.2010.113

1 reference

17 December 2017

Dimensions Publication ID

1003063835

0 references

1 reference

17 December 2017